title: TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).
abstract: Disturbances in Ca(2+) homeostasis have been implicated in a variety of neuropathological conditions including Parkinson's disease (PD). However, the importance of store-operated Ca(2+) entry (SOCE) channels in PD remains to be investigated. In the present study, we have scrutinized the significance of TRPC1 in 1-methyl-4-phenyl-1,2,3,6-tetrahyrdro-pyridine (MPTP)-induced PD using C57BL/6 animal model and PC12 cell culture model. Both sub-acute and sub-chronic treatments of MPTP significantly reduced TRPC1, and tyrosine hydroxylase levels, but not TRPC3, along with increased neuronal death. Furthermore, MPTP induces mitochondrial dysfunction, which was associated with reduced mitochondrial membrane potential, decreased level of Bcl(2), Bcl-xl, and an altered Bcl-xl/Bax ratio thereby initiating apoptosis. Importantly, TRPC1 overexpression in PC12 cells showed significant protection against MPP(+) induced neuronal apoptosis, which was attributed to the restoration of cytosolic Ca(2+) and preventing loss of mitochondrial membrane potential. Silencing of TRPC1 or addition of TRPC1 channel blockers decreased mitochondrial membrane potential, whereas activation of TRPC1 restored mitochondrial membrane potential in cells overexpressing TRPC1. TRPC1 overexpression also inhibited Bax translocation to the mitochondria and thereby prevented cytochrome c release and mitochondrial-mediated apoptosis. Overall, these results provide compelling evidence for the role of TRPC1 in either onset/progression of PD and restoration of TRPC1 levels could limit neuronal degeneration in MPTP mediated PD.
authors.affiliation: Department of Biochemistry & Molecular Biology, University of North Dakota, Grand Forks, 58201, United States.
authors.forename: Senthil
authors.initials: S
authors.lastname: Selvaraj
authors.forename: John A
authors.initials: JA
authors.lastname: Watt
authors.forename: Brij B
authors.initials: BB
authors.lastname: Singh
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000037:antagonists & inhibitors*; D000818:Animals; D017209:Apoptosis; D002118:Calcium / Q000378:metabolism; D045744:Cell Line, Tumor; D015259:Dopamine Agents / Q000633:toxicity*; D008297:Male; D053078:Membrane Potential, Mitochondrial / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D034622:RNA Interference; D051381:Rats; D050052:TRPC Cation Channels / Q000378:metabolism*
chemical_list: D015259:Dopamine Agents; D050052:TRPC Cation Channels; C096351:transient receptor potential cation channel, subfamily C, member 1; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D002118:Calcium
references.citation: J Cell Biol. 1997 Oct 6;139(1):205-17
references.pmid: 9314540
references.citation: Science. 2001 Apr 27;292(5517):727-30
references.pmid: 11326099
references.citation: Annu Rev Cell Dev Biol. 1999;15:269-90
references.pmid: 10611963
references.citation: Brain Res. 1995 Dec 18;704(2):240-45
references.pmid: 8788920
references.citation: Nat Rev Neurosci. 2006 Mar;7(3):207-19
references.pmid: 16495942
references.citation: J Biol Chem. 1999 Mar 19;274(12):8261-8
references.pmid: 10075732
references.citation: Neuroscience. 1991;44(1):185-204
references.pmid: 1770996
references.citation: J Biol Chem. 2007 Mar 23;282(12):9105-16
references.pmid: 17224452
references.citation: Clin Neuropharmacol. 1986;9(6):485-507
references.pmid: 3542203
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17542-7
references.pmid: 17956991
references.citation: J Cell Biol. 2002 Jun 24;157(7):1151-60
references.pmid: 12082077
references.citation: Trends Neurosci. 2009 May;32(5):249-56
references.pmid: 19307031
references.citation: Physiol Rev. 2005 Apr;85(2):757-810
references.pmid: 15788710
references.citation: In Vivo. 2004 Sep-Oct;18(5):561-9
references.pmid: 15523894
references.citation: Nature. 2003 Nov 20;426(6964):285-91
references.pmid: 14614461
references.citation: Biochem Soc Trans. 2007 Feb;35(Pt 1):96-100
references.pmid: 17233611
references.citation: Neurosci Lett. 1990 Sep 4;117(1-2):228-33
references.pmid: 1981254
references.citation: FASEB J. 2001 Jul;15(9):1652-4
references.pmid: 11427516
references.citation: Science. 1997 Jul 18;277(5324):370-2
references.pmid: 9219694
references.citation: Cell Tissue Res. 2004 Oct;318(1):215-24
references.pmid: 15503155
references.citation: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2837-42
references.pmid: 11226327
references.citation: Cell Calcium. 2003 Aug;34(2):169-75
references.pmid: 12810059
references.citation: Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7
references.pmid: 3872460
references.citation: Mol Biol Cell. 2006 Oct;17(10):4446-58
references.pmid: 16899508
references.citation: Neurosurgery. 1996 Jun;38(6):1176-95
references.pmid: 8727150
references.citation: Brain Res. 1987 Feb 10;403(1):43-51
references.pmid: 3493827
references.citation: J Biol Chem. 2009 Jul 3;284(27):18323-33
references.pmid: 19447887
references.citation: Eur J Pharmacol. 1986 Oct 7;129(3):339-45
references.pmid: 3490988
references.citation: J Biol Chem. 2001 Aug 24;276(34):32257-63
references.pmid: 11413128
references.citation: J Biol Chem. 2003 Apr 25;278(17):15381-9
references.pmid: 12584203
references.citation: J Neurochem. 1990 Mar;54(3):823-7
references.pmid: 2154550
references.citation: Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546-50
references.pmid: 6192438
references.citation: Nat Neurosci. 2005 Jun;8(6):730-5
references.pmid: 15880110
references.citation: Free Radic Biol Med. 2000 Aug;29(3-4):323-33
references.pmid: 11035261
references.citation: Mov Disord. 1998;13 Suppl 1:17-23
references.pmid: 9613714
references.citation: Nature. 2005 Apr 14;434(7035):898-904
references.pmid: 15758951
references.citation: Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):45-58
references.pmid: 1520406
references.citation: Nature. 1998 Jan 1;391(6662):43-50
references.pmid: 9422506
references.citation: Psychopharmacol Bull. 1984 Summer;20(3):548-53
references.pmid: 6332333
references.citation: Neurology. 2000;54(11 Suppl 5):S21-3
references.pmid: 10854357
references.citation: J Neurosci. 2005 Mar 9;25(10):2687-701
references.pmid: 15758179
references.citation: J Biol Chem. 2005 Jan 21;280(3):2132-40
references.pmid: 15542611
references.citation: Trends Neurosci. 1995 Feb;18(2):58-60
references.pmid: 7537408
references.citation: Brain Res Mol Brain Res. 2002 Dec 30;109(1-2):95-104
references.pmid: 12531519
references.citation: Neurobiol Dis. 2008 Jun;30(3):331-342
references.pmid: 18420416
references.citation: Cell Calcium. 1986 Feb;7(1):1-12
references.pmid: 2420465
references.citation: Nature. 2007 Jun 28;447(7148):1081-6
references.pmid: 17558391
references.citation: Eur J Pharmacol. 2007 Jun 14;564(1-3):47-56
references.pmid: 17362920
references.citation: J Biol Chem. 2003 Mar 28;278(13):11337-43
references.pmid: 12536150
references.citation: J Neurosci. 1999 Feb 15;19(4):1284-93
references.pmid: 9952406
references.citation: J Cereb Blood Flow Metab. 1999 Jan;19(1):1-18
references.pmid: 9886350